Search Results - "Koppikar, P"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    AKT is a therapeutic target in myeloproliferative neoplasms by Khan, I, Huang, Z, Wen, Q, Stankiewicz, M J, Gilles, L, Goldenson, B, Schultz, R, Diebold, L, Gurbuxani, S, Finke, C M, Lasho, T L, Koppikar, P, Pardanani, A, Stein, B, Altman, J K, Levine, R L, Tefferi, A, Crispino, J D

    Published in Leukemia (01-09-2013)
    “…The majority of patients with BCR-ABL1 -negative myeloproliferative neoplasms (MPN) harbor mutations in JAK2 or MPL, which lead to constitutive activation of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Identification of human papillomaviruses in tumors of the oral cavity in an Indian community by Koppikar, Priya, deVilliers, Ethel‐Michele, Mulherkar, Rita

    Published in International journal of cancer (01-03-2005)
    “…Oral cancers and other squamous cell cancers of the head and neck are common cancers in India, primarily due to tobacco chewing/smoking and alcohol…”
    Get full text
    Journal Article
  4. 4

    PF217 TARGETING FLT3 IN AML: MODULATION OF FLT3‐BITE® ACTIVITY THROUGH COMBINATION WITH VARIOUS TKI by Brauchle, B., Goldstein, R., Chi‐Ming, L., Buecklein, V., Krupka, C., Koppikar, P., Haubner, S., Thomas, O., Rock, D., Sastri, C., Cooke, K., Bergwelt‐Baildon, M., Metzeler, K.H., Spiekermann, K., Arvedson, T.L., Subklewe, M.

    Published in HemaSphere (01-06-2019)
    “…Background: T cell recruiting antibody constructs represent a novel platform for immunotherapy of acute myeloid leukemia (AML). We previously characterized…”
    Get full text
    Journal Article
  5. 5

    Intratumoral epidermal growth factor receptor (EGFR) antisense (AS) DNA in recurrent squamous cell carcinoma of the head and neck (SCCHN): A phase I trial by Lai, S. Y., Lui, V. W., Koppikar, P. J., Thomas, S. M., Gooding, W. E., Seethala, R. R., Branstetter, B. F., Argiris, A., Grandis, J. R.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 6009 Background: SCCHN is characterized by upregulation of the EGFR where EGFR expression levels in the tumor correlate with decreased survival…”
    Get full text
    Journal Article
  6. 6